Technical Analysis for BPMX - BioPharmX Corporation

Grade Last Price % Change Price Change
grade F 0.324 -2.56% -0.01
BPMX closed up 1.19 percent on Friday, August 16, 2019, on 17 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical BPMX trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.56%
Narrow Range Bar Range Contraction -2.56%
NR7 Range Contraction -2.56%
Wide Bands Range Expansion -2.56%
Oversold Stochastic Weakness -2.56%
Narrow Range Bar Range Contraction -1.40%
Wide Bands Range Expansion -1.40%
Oversold Stochastic Weakness -1.40%
Wide Bands Range Expansion -0.70%
Oversold Stochastic Weakness -0.70%

Older signals for BPMX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women's health, dermatology, and otolaryngology markets. The company offers prescription, over-the-counter (OTC), and supplement products in oral, topical, inhalant, and/or injectable forms. It provides VI2OLET iodine, an OTC dietary supplement molecular iodine tablet that promotes overall breast health and for the alleviation of benign breast pain associated with fibrocystic breast condition. The company's clinical-stage product candidates include BPX03, a molecular iodine tablet for the treatment of benign breast pain associated with FBC and cyclic mastalgia; and BPX01, a non-lipophilic topical antibiotic for the treatment of acne. It serves pharmaceutical companies; physician's practices, including OB-Gyn's, dermatologists, and general practioners; and retail customers through retail sales channels and/or pharmacy outlets. The company has collaboration and licensing agreement with Iogen LLC for the development of molecular iodine products; and collaboration and supply agreement with NuTech Medical, Inc. to develop products in the field of dermatology. BioPharmX Corporation is headquartered in Menlo Park, California.
Chemistry Health Pharmaceutical Retail Customers Pharmacology Breast Cancer Acne Drug Delivery Dietary Supplement Over The Counter Drug Dermatology Topical Medication
Is BPMX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.75
52 Week Low 0.3
Average Volume 1,001,679
200-Day Moving Average 2.0744
50-Day Moving Average 0.559
20-Day Moving Average 0.3749
10-Day Moving Average 0.3329
Average True Range 0.0404
ADX 19.86
+DI 15.1744
-DI 24.11
Chandelier Exit (Long, 3 ATRs ) 0.3688
Chandelier Exit (Short, 3 ATRs ) 0.4212
Upper Bollinger Band 0.4713
Lower Bollinger Band 0.2785
Percent B (%b) 0.28
BandWidth 51.427047
MACD Line -0.0681
MACD Signal Line -0.0788
MACD Histogram 0.0108
Fundamentals Value
Market Cap 26.49 Million
Num Shares 79.7 Million
EPS -0.32
Price-to-Earnings (P/E) Ratio -1.06
Price-to-Sales 185.99
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.36
Resistance 3 (R3) 0.36 0.35 0.36
Resistance 2 (R2) 0.35 0.34 0.35 0.36
Resistance 1 (R1) 0.34 0.34 0.35 0.34 0.35
Pivot Point 0.33 0.33 0.33 0.33 0.33
Support 1 (S1) 0.32 0.32 0.33 0.32 0.31
Support 2 (S2) 0.31 0.32 0.31 0.31
Support 3 (S3) 0.30 0.31 0.31
Support 4 (S4) 0.30